LONA Q4 2020 Earnings — LeonaBio, Inc. Revenue & Financial Results | Market Cap Arena

LONALeonaBio, Inc.

$26M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$9M

Net Income

-$8M

EPS (Diluted)

$-2.40

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$13M

Stock-Based Comp.

$415,000

Balance Sheet

Total Assets

$280M

Total Liabilities

$5M

Stockholders' Equity

$274M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$9M	-$1M	-712.8%
Net Income	-$8M	-$974,000	-690.8%